Systemic lupus erythematosus vaccine - Abraxis BioScience/MedClone
Alternative Names: 3E10 - American Bioscience/MedClone; 3E10 vaccine; Lupus nephritis vaccine - American Bioscience/MedClone; Monoclonal antibody 3E10Latest Information Update: 28 Aug 2006
At a glance
- Originator Abraxis BioScience; American BioScience; MedClone
- Developer American BioScience; MedClone
- Class Monoclonal antibodies; Vaccines
- Mechanism of Action Immunostimulants; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Lupus nephritis; Systemic lupus erythematosus
Most Recent Events
- 28 Aug 2006 Discontinued - Phase-I for Lupus nephritis in USA (Intradermal)
- 28 Aug 2006 Discontinued - Phase-I for Systemic lupus erythematosus in USA (Intradermal)
- 20 Oct 2004 No development reported - Phase-I for Lupus nephritis in USA (Intradermal)